AKT1 and hepatocellular carcinoma: Apart from cell‐line‐derived tumor models, the combination therapy retarded the tumor development and extended survival in the AKT/Ras‐driven spontaneous hepatocellular carcinoma (HCC) model (Figure 6p–r) (Figure S17d, Supporting Information).